Inventor · disambiguated record
Michael James Waring
Also filed as: WARING MICHAEL · WARING MICHAEL J · WARING MICHAEL JAMES
25 granted patents·18 pending applications·116 citations·filing 1991–2022
95Inventor score
Files withASTRAZENECA AB19BIRCH ALAN MARTIN3PQ SILICAS UK LTD3ANDREWS DAVID MICHAEL2BENNETT STUART NORMAN LILE2
Top patents by PatentIndex Score
43 records- 0194US7745475B2Heteroaryl benzamide derivatives as GLK activatorsASTRAZENECA AB·Filed 2005·Granted Jun 29, 2010·14 cites·3 claims
- 0293US7642259B2Heteroaryl benzamide derivatives for use as GLK activators in the treatment of diabetesASTRAZENECA AB·Filed 2006·Granted Jan 5, 2010·18 cites·3 claims
- 0392US7642263B2Heteroaryl benzamide derivatives for use as GLK activators in the treatment of diabetesASTRAZENECA AB·Filed 2008·Granted Jan 5, 2010·16 cites·3 claims
- 0490US7842694B2Heteroaryl benzamide derivatives for use as GLK activators in the treatment of diabetesASTRAZENECA AB·Filed 2008·Granted Nov 30, 2010·11 cites·3 claims
- 0588US7671060B2Heteroaryl benzamide derivativesASTRAZENECA AB·Filed 2007·Granted Mar 2, 2010·13 cites·3 claims
- 0686US9944650B2[1,2,4]triazolo[4,3-B]pyridazines for use in the treatment of proliferative diseasesASTRAZENECA AB·Filed 2015·Granted Apr 17, 2018·5 cites·8 claims
- 0783US10766905B2[1,2,4]triazolo[4,3-B]pyridazines for use in the treatment of proliferative diseasesASTRAZENECA AB·Filed 2019·Granted Sep 8, 2020·1 cites·8 claims
- 0883US10407432B2[1,2,4]triazolo[4,3-B]pyridazines for use in the treatment of proliferative diseasesASTRAZENECA AB·Filed 2018·Granted Sep 10, 2019·3 cites·8 claims
- 0977US8188092B2Substituted pyrazines as DGAT-1 inhibitorsBIRCH ALAN MARTIN·Filed 2010·Granted May 29, 2012·7 cites·13 claims
- 1073US7902200B2Chemical compoundsASTRAZENECA AB·Filed 2007·Granted Mar 8, 2011·4 cites·9 claims
- 1171US8207202B2Benzamide compounds useful as histone deacetylase inhibitorsANDREWS DAVID MICHAEL·Filed 2006·Granted Jun 26, 2012·2 cites·8 claims
- 1270US2023035133A1[1,2,4]Triazolo[4,3-B]Pyridazines For Use in the Treatment of Proliferative DiseasesASTRAZENECA AB·Filed 2022·Application pending·0 cites
- 1369US7897778B2Benzamide compoundsASTRAZENECA·Filed 2005·Granted Mar 1, 2011·1 cites·14 claims
- 1466US11407755B2[1,2,4]triazolo[4,3-b]pyridazines for use in the treatment of proliferative diseasesASTRAZENECA AB·Filed 2020·Granted Aug 9, 2022·0 cites·15 claims
- 1565US7977328B2Heteroaryl benzamide derivatives for use as GLK activators in the treatment of diabetesASTRAZENECA AB·Filed 2008·Granted Jul 12, 2011·0 cites·12 claims
- 1664US7964725B2Heteroarylbenzamide derivatives for use in the treatment of diabetesASTRAZENECA AB·Filed 2009·Granted Jun 21, 2011·0 cites·1 claims
- 1762US2009029991A1Benzamide derivatives useful as histone deacetylase inhibitorsASTRAZENECA AB·Filed 2008·Application pending·0 cites
- 1862US2021023262A1Composition and dressing with nitric oxidePQ SILICAS UK LTD·Filed 2020·Application pending·0 cites
- 1959US2009253676A1Heteroaryl Benzamide Derivatives for Use as GLK Activators in the Treatment of DiabetesASTRAZENECA AB·Filed 2008·Application pending·0 cites
- 2057US10821203B2Composition and dressing with nitric oxidePQ SILICAS UK LTD·Filed 2017·Granted Nov 3, 2020·0 cites·19 claims
- 2157US2011280927A1Composition and dressing with nitric oxideARAYA ABRAHAM·Filed 2009·Application pending·0 cites
- 2256US10835636B2Composition and dressing with nitric oxidePQ SILICAS UK LTD·Filed 2014·Granted Nov 17, 2020·0 cites·19 claims
- 2352US2005171103A1Benzamide derivatives useful as histone deacetylase inhibitorsASTRAZENECA AB·Filed 2003·Application pending·0 cites
- 2447US8735429B2Benzamide compounds useful as histone deacetylase inhibitorsANDREWS DAVID MICHAEL·Filed 2012·Granted May 27, 2014·0 cites·7 claims
- 2547US2011053910A12 -heterocyclyloxybenzoyl amino heterocyclyl compounds as modulators of glucokinase for the treatment of type 2 diabetesMCKERRECHER DARREN·Filed 2006·Application pending·0 cites
- 2646US8247562B2Benzamide derivatives useful as histone deacetylase inhibitorsSTOKES ELAINE SOPHIE ELIZABETH·Filed 2010·Granted Aug 21, 2012·0 cites·5 claims
- 2745US7943607B2Heteroaryl benzamide derivatives for use as GLK activators in the treatment of diabetesASTRAZENECA AB·Filed 2006·Granted May 17, 2011·0 cites·17 claims
- 2845US2010075942A1N-phenyl-4-pyridin-2-yl-benzamide derivatives as histone deacylase (hdac) inhibitors for the treatment of cancerASTRAZENECA AB·Filed 2006·Application pending·0 cites
- 2945US2011092547A1Chemical compounds 979BIRCH ALAN MARTIN·Filed 2008·Application pending·0 cites
- 3045US2008119451A1Novel Benzamide DerivativesASTRAZENECA AB·Filed 2006·Application pending·0 cites
- 3145US2008280874A1Phenoxy Benzamide Compounds with Utility in the Treatment of Type 2 Diabetes and ObesityJOHNSTONE CRAIG·Filed 2005·Application pending·0 cites
- 3244US2008234273A1Heteroaryl Benzamide Derivatives for Use as Glk Activators in the Treatment of DiabetesMCKERRECHER DARREN·Filed 2006·Application pending·0 cites
- 3344US2011059941A12-phenyl substituted imidazol [4,5b] pyridine/pyrazine and purine derivatives as glucokinase modulatorsCAULKETT PETER WILLIAM RODNEY·Filed 2006·Application pending·0 cites
- 3442US2009105263A1Heterobicyclic compounds as glucokinase activatorsCAULKETT PETER WILLIAM RODNEY·Filed 2006·Application pending·0 cites
- 3541US2007287693A1Benzamide Derivatives That Act Upon The Glucokinase EnzymeJOHNSTONE CRAIG·Filed 2005·Application pending·0 cites
- 3640US5215600AThermomechanical treatment of Ti 6-2-2-2-2ROHR INC·Filed 1991·Granted Jun 1, 1993·9 cites·10 claims
- 3740US2012289520A1Chemical compounds 785BIRCH ALAN MARTIN·Filed 2012·Application pending·0 cites
- 3840US2006292109A1Enzyme inhibiting sprayable compositionsBRISTOL MYERS SQUIBB CO·Filed 2006·Application pending·0 cites
- 3938US8071585B2Therapeutic agentsWARING MICHAEL JAMES·Filed 2010·Granted Dec 6, 2011·0 cites·5 claims
- 4036US5906601AUse of an adhesive composition in the manufacture of a wound dressingBRISTOL MYERS SQUIBB CO·Filed 1996·Granted May 25, 1999·12 cites·9 claims
- 4135US8143263B2Therapeutic agentsBENNETT STUART NORMAN LILE·Filed 2009·Granted Mar 27, 2012·0 cites·3 claims
- 4234US8071608B2Therapeutic agentsBENNETT STUART NORMAN LILE·Filed 2010·Granted Dec 6, 2011·0 cites·5 claims
- 4329US2002127269A1Multi-dose wound gelFiled 1998·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Michael James Waring files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →